2026 ICD-10-CM Diagnosis Code T80.1XXSVascular complications following infusion, transfusion and therapeutic injection, sequela
T80.1XXS is a billable ICD-10-CM diagnosis code for vascular complications following infusion, transfusion and therapeutic injection, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. Coders also document this condition as necrosis following injection of local anesthetic. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Complication, sequela.
Code Identity
Code Classification
Present on Admission (POA)Billing
T80.1XXS is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Necrosis following injection of local anesthetic
- Phlebitis after infusion
- Phlebitis following perfusion
- Phlebitis following transfusion
- Pseudoaneurysm of vascular access site
- Superficial thrombophlebitis following administration of drug via intravenous route
- Thromboembolism after infusion
- Thrombophlebitis after infusion
- Thrombophlebitis following perfusion
- Thrombophlebitis following transfusion
Coding GuidelinesGuidance
The appropriate 7th character is to be added to each code from block Complications following infusion, transfusion and therapeutic injection (T80). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Convert T80.1XXS to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About T80.1XXSOverview
Is T80.1XXS a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report vascular complications following infusion, transfusion and therapeutic injection, sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What does the 7th character S in T80.1XXS mean?
The final character S makes this a sequela code: it reports a lingering problem that remains after the vascular complications following infusion, transfusion and therapeutic injection itself has resolved, not the original event.
What MS-DRG does T80.1XXS group to?
When vascular complications following infusion, transfusion and therapeutic injection, sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.
Is T80.1XXS exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for vascular complications following infusion, transfusion and therapeutic injection, sequela on inpatient claims.
What is the ICD-9 equivalent of T80.1XXS?
Under the General Equivalence Mappings, vascular complications following infusion, transfusion and therapeutic injection, sequela converts to ICD-9-CM 909.3 (late eff surg/med compl). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
